Variant report
Variant | esv3496604 |
---|---|
Chromosome Location | chr20:23103199-23103741 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:23085800-23114600 | Enhancers | Placenta | Placenta |
2 | chr20:23093000-23103200 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr20:23097600-23110200 | Weak transcription | Pancreas | Pancrea |
4 | chr20:23098000-23106000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr20:23099600-23104600 | Weak transcription | Placenta Amnion | Placenta Amnion |
6 | chr20:23099800-23105400 | Weak transcription | Gastric | stomach |
7 | chr20:23100000-23103200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr20:23100000-23104000 | Weak transcription | GM12878-XiMat | blood |
9 | chr20:23100200-23103400 | Weak transcription | Primary B cells from cord blood | blood |
10 | chr20:23100200-23111200 | Enhancers | Fetal Thymus | thymus |
11 | chr20:23100400-23103200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr20:23100400-23106000 | Weak transcription | Colonic Mucosa | Colon |
13 | chr20:23100600-23103200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr20:23100600-23103200 | Flanking Active TSS | Dnd41 | blood |
15 | chr20:23101000-23104400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr20:23101000-23104600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr20:23101200-23105400 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
18 | chr20:23101200-23106600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
19 | chr20:23101200-23109400 | Weak transcription | Liver | Liver |
20 | chr20:23101400-23103200 | Enhancers | K562 | blood |
21 | chr20:23101400-23105800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
22 | chr20:23101400-23106000 | Weak transcription | Adipose Nuclei | Adipose |
23 | chr20:23101600-23103200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr20:23101600-23103200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
25 | chr20:23101600-23104600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
26 | chr20:23101800-23106000 | Weak transcription | Left Ventricle | heart |
27 | chr20:23101800-23109200 | Weak transcription | Right Ventricle | heart |
28 | chr20:23102000-23104600 | Weak transcription | Esophagus | oesophagus |
29 | chr20:23102000-23105800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
30 | chr20:23102000-23105800 | Weak transcription | Lung | lung |
31 | chr20:23102000-23106200 | Weak transcription | Right Atrium | heart |
32 | chr20:23102000-23106600 | Weak transcription | Spleen | Spleen |
33 | chr20:23102000-23114000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
34 | chr20:23102600-23103200 | Enhancers | Primary hematopoietic stem cells | blood |
35 | chr20:23102800-23105000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
36 | chr20:23103200-23104600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
37 | chr20:23103200-23104600 | Enhancers | Dnd41 | blood |
38 | chr20:23103200-23105400 | Weak transcription | K562 | blood |
39 | chr20:23103200-23105800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
40 | chr20:23103200-23105800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
41 | chr20:23103200-23106000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
42 | chr20:23103200-23106400 | Weak transcription | Primary hematopoietic stem cells | blood |
43 | chr20:23103200-23109800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
44 | chr20:23103400-23104000 | Enhancers | Primary B cells from cord blood | blood |